NCT00060814View on ClinicalTrials.gov

Combination Pharmacotherapy for Smoking Cessation Among Methadone Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

September 30, 2002

Study Completion Date

December 31, 2002

Conditions
Tobacco Use Disorder
Interventions
OTHER

Combined intervention

300 mg bupropion plus 4mg nicotine gum ad lib plus motivational interviewing counseling

Trial Locations (1)

66160 7420

University of Kansas Medical Center, Kansas City

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00060814 - Combination Pharmacotherapy for Smoking Cessation Among Methadone Patients | Biotech Hunter | Biotech Hunter